Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis - Fuente-Sandoval, Camilo de la; León-Ortiz, Pablo; Favila, Rafael; Stephano, Sylvana; Mamo, David; Ramírez-Bermúdez, Jesús; Graff-Guerrero, Ariel (Neuropsychopharmacology (New York, N.Y.), 2011)
Keywords: 631/378/1457/1936; 631/378/1689/1761; 631/378/548/1964; 692/699/476/1799; Adolescent; Adult; Adult and adolescent clinical studies; Age of Onset; Behavioral Sciences; Biological and medical sciences; Biological Psychology; Caudate Nucleus - metabolism; Caudate Nucleus - pathology; Caudate Nucleus - physiopathology; Disease Progression; Female; Glutamic Acid - metabolism; Humans; Male; Medical sciences; Medicine; Medicine & Public Health; Neurosciences; Original; original-article; Pharmacotherapy; Psychiatry; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychoses; Psychosis; Psychotic Disorders - diagnosis; Psychotic Disorders - metabolism; Psychotic Disorders - physiopathology; Risk Factors; Schizophrenia; Schizophrenia - diagnosis; Schizophrenia - metabolism; Schizophrenia - physiopathology; Up-Regulation - physiology; Young Adult; associative-striatum; schizophrenia; H-MRS; prodromal; dopamine; glutamate; Human; Dopamine; Central nervous system; Schizophrenia; Prodrome; Basal ganglion; Corpus striatum; Catecholamine; Glutamate; Encephalon; Psychosis; Symptomatology; First episode; Excitatory aminoacid; Neurotransmitter